have validated microglia gene targets for a number of MPRA functional regulatory variants using CRISPR-excision and CRISPRi, including the AD-risk genes CR1, SPI1, CELF1, MS4A4E, RIN3, KNOP1, BIN1 and EPHA1 (106). This evidence concerns the gene BIN1 and Alzheimer disease.